Study finds key metabolic changes in patients with chemotherapy-associated cardiotoxicity
More and more patients are being treated successfully for cancer. However, some cancer treatments that…
Browsing: chemotherapy
De-escalating breast cancer therapy; can some patients be spared chemotherapy?
About one of every five breast cancers presents with high levels of HER2 proteins. Known…
A homing beacon for chemotherapy drugs
Killing tumour cells while sparing their normal counterparts is a central challenge of cancer chemotherapy.…
Carboplatin & paclitaxel chemotherapy alone should remain standard treatment for endometrial cancer
The New England Journal of Medicine recently published the primary endpoint of the NRG Oncology clinical…
EHA 2019: Overcoming the “Don’t Eat Me” signal of refractory lymphomas
Chemotherapy for non-Hodgkin’s lymphomas is highly effective for most patients. In aggressive lymphomas, such as…
ASCO 2019: Immunotherapy better than aggressive chemotherapy as first treatment option for recurrent head and neck cancer
Immunotherapy used with chemotherapy or on its own is a better first-line treatment for people…
Pancreatic cancer specialist explains challenges of the disease and treatment advances
Nathan Bahary, University of Pittsburgh With Alex Trebek’s recent announcement that his pancreatic cancer is…
ASCO 2019: Front-line pembrolizumab is promising alternative to chemotherapy for advanced gastroesophageal junction and gastric cancers
The KEYNOTE-062 phase III randomised clinical trial achieved its primary endpoint, showing that for patients…
‘I’m here for breast cancer. Why are you talking to me about my heart?’
Many physicians are not telling cancer patients about the cardiotoxicity risks of treatments and may…
Global study predicts more than 50% rise in chemotherapy demand by 2040
Between 2018 and 2040, the number of patients requiring first-line chemotherapy treatment each year is…